Nutritional Study to Evaluate the Impact of Advanced Nutritional
Supplementation (ANS) for Lipizzan Stallion Horses on Overall Health
In this 10-month, randomized, single-blind, cross-over design study,
each of three pairs of genetically-related stallion horses were assigned
to enter the study in either the active group or the control group, and
to complete the study in the alternate group.
Group A began the study in the active group and completed the
study in the control group; Group B was assigned reciprocally.
All horses were between five and seven years of age and were in good
health. The horses remained on their routine feed for the entire study
regardless of phase or group assignment.
The test supplement, ANS, was administered to the active groups twice
daily as K.A.M. ALL IN ONE Equine Supplement, KLPP and UF Formula.
Following a baseline evaluation and randomization, safety and efficacy
assessments were completed every 60 days separated by a 60-day washout
or titration period. All assessments were performed by a licensed
veterinarian who was blinded to group assignment.
Results of overall health assessments, blood samples for CBC, Chemistry
and T4, were within normal limits, and remained unchanged throughout the
study for all horses.
Sperm motility improved consistently at 24 and 48 hours for one horse
while receiving ANS. One horse was sound at study entry and was
randomized to Group A; this horse remained sound while receiving ANS,
but experienced grade 1-2 lameness following washout. A second horse in
Group A experienced an injury during the active phase that resolved
prior to entering the control phase. The remaining horse in Group A was
lame at the baseline visit but became sound while receiving ANS and
remained sound following transition to the control group. All horses in
Group B were lame at the baseline visit but became sound after the
addition of ANS to their usual feed.